16
Participants
Start Date
February 28, 2010
Primary Completion Date
March 31, 2013
Study Completion Date
March 13, 2017
LBH589
Taken orally three times per week.
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Brigham and Women's Hospital
OTHER
Novartis
INDUSTRY
Dana-Farber Cancer Institute
OTHER